• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过网络药理学和分子对接揭示葫芦素D对结直肠癌的抗癌机制。

Uncovering the anti-cancer mechanism of cucurbitacin D against colorectal cancer through network pharmacology and molecular docking.

作者信息

Lim Hae-In, Kim Ga Yoon, Choi Yu-Jeong, Lee Kangwook, Ko Seong-Gyu

机构信息

Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.

College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul, 08826, Republic of Korea.

出版信息

Discov Oncol. 2025 Apr 17;16(1):551. doi: 10.1007/s12672-025-02056-7.

DOI:10.1007/s12672-025-02056-7
PMID:40244518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12006582/
Abstract

Colorectal cancer is a significant global health challenge due to chemoresistance, necessitating new treatments. Cucurbitacin D, with its anti-cancer properties, shows promise, but its effects on colorectal cancer are not well understood. We investigated the impact of cucurbitacin D on colorectal cancer cell lines using MTT assays and Annexin V/7-AAD staining followed by flow cytometry for apoptosis analysis. Public databases helped identify cucurbitacin D and colorectal cancer-related gene targets for network pharmacology analysis. Protein-protein interaction networks were constructed using STRING and analyzed in Cytoscape. Gene ontology and KEGG pathway enrichment analyses were performed using ClueGo. Molecular docking studies were conducted via Autodock Vina and visualized in Discovery Studio. Western blot assessed protein expression changes in key targets under cucurbitacin D. Cucurbitacin D dose-dependently reduced colorectal cancer cell viability and induced apoptosis. Network pharmacology pinpointed crucial targets like STAT3, AKT1, CCND1, and CASP3. Molecular docking confirmed strong interactions with these targets. Enrichment analysis highlighted involvement in the 'PI3K-AKT,' 'JAK-STAT,' and 'ErbB' signaling pathways. These findings suggest cucurbitacin D as a potential anti-colorectal cancer agent, demonstrating significant effects on cell viability and apoptosis, and engaging critical cancer-related pathways, making it a promising candidate for further colorectal cancer therapeutic research.

摘要

由于化疗耐药性,结直肠癌是一项重大的全球健康挑战,因此需要新的治疗方法。葫芦素D具有抗癌特性,显示出了前景,但其对结直肠癌的影响尚未得到充分了解。我们使用MTT法和Annexin V/7-AAD染色,随后通过流式细胞术进行凋亡分析,研究了葫芦素D对结直肠癌细胞系的影响。公共数据库有助于识别葫芦素D和与结直肠癌相关的基因靶点,用于网络药理学分析。使用STRING构建蛋白质-蛋白质相互作用网络,并在Cytoscape中进行分析。使用ClueGo进行基因本体论和KEGG通路富集分析。通过Autodock Vina进行分子对接研究,并在Discovery Studio中进行可视化。蛋白质免疫印迹法评估了葫芦素D作用下关键靶点的蛋白质表达变化。葫芦素D剂量依赖性地降低了结直肠癌细胞活力并诱导凋亡。网络药理学确定了STAT3、AKT1、CCND1和CASP3等关键靶点。分子对接证实了与这些靶点的强相互作用。富集分析突出了其参与“PI3K-AKT”、“JAK-STAT”和“ErbB”信号通路。这些发现表明葫芦素D是一种潜在的抗结直肠癌药物,对细胞活力和凋亡具有显著影响,并涉及关键的癌症相关通路,使其成为进一步结直肠癌治疗研究的有希望的候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/84d66f02deac/12672_2025_2056_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/29ade790b4eb/12672_2025_2056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/fb63cbd44f63/12672_2025_2056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/22627b51f232/12672_2025_2056_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/6661e737cc66/12672_2025_2056_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/79023bd41093/12672_2025_2056_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/57b77c001217/12672_2025_2056_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/84d66f02deac/12672_2025_2056_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/29ade790b4eb/12672_2025_2056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/fb63cbd44f63/12672_2025_2056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/22627b51f232/12672_2025_2056_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/6661e737cc66/12672_2025_2056_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/79023bd41093/12672_2025_2056_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/57b77c001217/12672_2025_2056_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/12006582/84d66f02deac/12672_2025_2056_Fig7_HTML.jpg

相似文献

1
Uncovering the anti-cancer mechanism of cucurbitacin D against colorectal cancer through network pharmacology and molecular docking.通过网络药理学和分子对接揭示葫芦素D对结直肠癌的抗癌机制。
Discov Oncol. 2025 Apr 17;16(1):551. doi: 10.1007/s12672-025-02056-7.
2
Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.基于网络药理学、分子对接和实验验证的八珍汤治疗大肠癌的作用机制。
Front Immunol. 2023 Sep 20;14:1235575. doi: 10.3389/fimmu.2023.1235575. eCollection 2023.
3
[Mechanism of osthole against colorectal cancer based on network pharmacology, molecular docking, and experimental validation].基于网络药理学、分子对接和实验验证的蛇床子素抗结直肠癌作用机制
Zhongguo Zhong Yao Za Zhi. 2024 Nov;49(21):5752-5761. doi: 10.19540/j.cnki.cjcmm.20240712.703.
4
Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.采用网络药理学和细胞研究方法探讨山乌龟-败酱草药对对结直肠癌细胞中 PI3K/AKT/mTOR 信号通路诱导细胞凋亡的作用机制。
J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117342. doi: 10.1016/j.jep.2023.117342. Epub 2023 Oct 23.
5
A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.基于网络药理学方法和实验验证,探讨味通心通过诱导 PI3K/AKT 信号通路细胞凋亡对结肠癌的抗癌机制和潜在的活性靶点。
J Ethnopharmacol. 2023 Mar 1;303:115933. doi: 10.1016/j.jep.2022.115933. Epub 2022 Nov 18.
6
Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.基于网络药理学和生物信息学验证的人参对结直肠癌肿瘤微环境调控机制的研究。
Curr Comput Aided Drug Des. 2024;20(5):486-500. doi: 10.2174/1573409919666230607103721.
7
[Mechanism of Huachansu Injection against colorectal cancer based on network pharmacology and cellular experimental].基于网络药理学和细胞实验的华蟾素注射液抗结直肠癌作用机制研究
Zhongguo Zhong Yao Za Zhi. 2024 Sep;49(17):4755-4767. doi: 10.19540/j.cnki.cjcmm.20240426.501.
8
Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.基于网络药理学和分子对接技术探究黄连-生姜对抗结肠癌的活性成分及作用机制。
Technol Health Care. 2024;32(S1):523-542. doi: 10.3233/THC-248046.
9
Network pharmacology and experimental validation to explore the role and potential mechanism of Liuwei Dihuang Decoction in prostate cancer.网络药理学与实验验证探讨六味地黄汤在前列腺癌中的作用及潜在机制。
BMC Complement Med Ther. 2024 Jul 26;24(1):284. doi: 10.1186/s12906-024-04572-5.
10
Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.铁皮石斛中的主要活性成分鼓槌石斛碱通过网络药理学和体外实验验证,通过抑制 HRAS-PI3K-AKT 信号通路抑制胃癌前病变(PLGC)。
J Ethnopharmacol. 2021 Oct 28;279:114399. doi: 10.1016/j.jep.2021.114399. Epub 2021 Jul 8.

引用本文的文献

1
Safety Evaluation of SH003 and Docetaxel Combination in Patients With Breast and Lung Cancer: A Multi-Center, Open-Label, Dose Escalation Phase I Clinical Trial.SH003与多西他赛联合用药治疗乳腺癌和肺癌患者的安全性评估:一项多中心、开放标签、剂量递增的I期临床试验。
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251363892. doi: 10.1177/15347354251363892. Epub 2025 Aug 9.
2
Decoding the JAK-STAT Axis in Colorectal Cancer with AI-HOPE-JAK-STAT: A Conversational Artificial Intelligence Approach to Clinical-Genomic Integration.利用AI-HOPE-JAK-STAT解码结直肠癌中的JAK-STAT轴:一种临床基因组整合的对话式人工智能方法
Cancers (Basel). 2025 Jul 17;17(14):2376. doi: 10.3390/cancers17142376.

本文引用的文献

1
The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain.去甲肾上腺素能系统在葫芦素D对紫杉醇诱导的小鼠神经性疼痛的抗伤害感受作用中的参与。
Front Pharmacol. 2023 Jan 4;13:1055264. doi: 10.3389/fphar.2022.1055264. eCollection 2022.
2
Current Targeted Therapy for Metastatic Colorectal Cancer.转移性结直肠癌的当前靶向治疗。
Int J Mol Sci. 2023 Jan 15;24(2):1702. doi: 10.3390/ijms24021702.
3
Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
新型天然小分子 NSC772864 作为调节结直肠癌细胞周期进展的原癌基因潜在抑制剂的多组学研究
Cells. 2023 Jan 16;12(2):340. doi: 10.3390/cells12020340.
4
Novel strategies to reverse chemoresistance in colorectal cancer.新型策略逆转结直肠癌的化疗耐药性。
Cancer Med. 2023 May;12(10):11073-11096. doi: 10.1002/cam4.5594. Epub 2023 Jan 16.
5
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
6
Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study.基于网络药理学和分子对接研究探讨走马胎对结直肠癌的作用机制。
BMC Complement Med Ther. 2023 Jan 9;23(1):4. doi: 10.1186/s12906-022-03822-8.
7
PubChem 2023 update.PubChem 2023 更新。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1373-D1380. doi: 10.1093/nar/gkac956.
8
A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer.基于网络的药理学研究以确定穿心莲内酯抗结直肠癌的机制调控途径。
Front Pharmacol. 2022 Aug 30;13:967262. doi: 10.3389/fphar.2022.967262. eCollection 2022.
9
Anti-Colon Cancer Activity of Dietary Phytochemical Soyasaponin I and the Induction of Metabolic Shifts in HCT116.膳食植物化学大豆皂甙 I 的抗结肠癌活性及其对 HCT116 代谢重编程的诱导作用。
Molecules. 2022 Jul 8;27(14):4382. doi: 10.3390/molecules27144382.
10
Analgesic Effect of SH003 and Maximowicz in Paclitaxel-Induced Neuropathic Pain in Mice.SH003和马克西莫维茨对小鼠紫杉醇诱导的神经性疼痛的镇痛作用。
Curr Issues Mol Biol. 2022 Jan 31;44(2):718-730. doi: 10.3390/cimb44020050.